Research Registry - Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO)

Clinical Trial Details

The Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF-PRO) aims to:

Collect information regarding the natural history of IPF and healthcare interactions
Describe quality of life of IPF participants with patient reported questionnaires
Assess the methods of treatment of participants
Collect blood specimens for future research projects

Key Eligibility:

Participants with a newly established diagnosis of IPF who are able to read and write in English, are 40 years or older, and are willing and able to provide informed consent may be eligible to participate.

Return to List